Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.67 |
| ▸ | PPARD | Q03181 | 5/20 | 0.67 |
| ▸ | PPARA | Q07869 | 5/20 | 0.67 |
| ▸ | F7 | P08709 | 5/20 | 0.67 |
| ▸ | F3 | P13726 | 5/20 | 0.67 |
| ▸ | TERT | O14746 | 3/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | FABP4 | P15090 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | FAAH | O00519 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148146 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL11153973 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL11153977 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL3946252 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL11546605 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL7107170 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL3219062 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2287017 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL7107183 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL11161477 | 1.00 | PPARG (0.67) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115135720-B | Polyester elastomer resin composition | 东洋纺MC株式会社 | 2024-04-23 | — | — | CN | disclosed |
| US-20230140068-A1 | POLYESTER ELASTOMER RESIN COMPOSITION | TOYOBO CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230096466-A1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | NOVOCHIZOL SA (CH) | 2023-03-30 | — | — | US | disclosed |
| CN-115135720-A | Polyester elastomer resin composition | 东洋纺株式会社 | 2022-09-30 | — | — | CN | disclosed |
| EP-3865535-A1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | Bosti Trading Ltd. (CY) | 2021-08-18 | — | — | EP | disclosed |
| CN-1066313-C | Safened herbicidal sulfonamide compositions | MONSANTO CO (US) | 2001-05-30 | — | — | CN | disclosed |
| CN-1074464-A | The particulate opacifying extender that is used for polymer coating | KERR MC GEE CHEM CORP (US) | 1993-07-21 | — | — | CN | disclosed |
| CN-1063015-A | Safe herbicidal sulfonamide compositions | MONSANTO CO (US) | 1992-07-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096466-A1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | CHIA, CHIT1, CHI3L2 | PPARG 4841/4885PPARD 4689/4885PPARA 4531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.